Media coverage about Cardiovascular Systems (NASDAQ:CSII) has been trending somewhat positive on Friday, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardiovascular Systems earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave news headlines about the medical device company an impact score of 46.1790134190041 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Several brokerages have issued reports on CSII. BidaskClub cut shares of Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a research note on Wednesday. Raymond James Financial began coverage on shares of Cardiovascular Systems in a research note on Friday, September 22nd. They set a “market perform” rating on the stock. Needham & Company LLC cut shares of Cardiovascular Systems from a “buy” rating to a “hold” rating and lowered their target price for the stock from $33.11 to $23.00 in a research note on Friday, December 15th. Zacks Investment Research cut shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Finally, William Blair reaffirmed a “market perform” rating on shares of Cardiovascular Systems in a research note on Thursday, December 21st. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $31.50.
Shares of Cardiovascular Systems (CSII) opened at $23.89 on Friday. Cardiovascular Systems has a one year low of $23.00 and a one year high of $33.11. The company has a current ratio of 4.30, a quick ratio of 3.83 and a debt-to-equity ratio of 0.18. The stock has a market cap of $790.41, a price-to-earnings ratio of -398.17 and a beta of 2.52.
TRADEMARK VIOLATION NOTICE: This story was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.com-unik.info/2018/01/12/cardiovascular-systems-csii-given-daily-news-impact-rating-of-0-09.html.
About Cardiovascular Systems
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
What are top analysts saying about Cardiovascular Systems? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardiovascular Systems and related companies.